DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
+106%
US · US
DHR.US latest organized financial period shows revenue lacks a complete YoY comparison and net income declined -7.31% YoY. Current price is about 178 USD, while the model base case is about 76.84 USD; the current price sits +132% versus the base case. The page shows both reported and adjusted views; valuation still defaults to reported figures, while adjusted figures help isolate structured one-time-item impact. This summary is intended for public-information research and model review.
Annual financial metrics with switchable views. · Unit: USD
Price date: 2026/04/29 · Updated: 2026/04/29 15:26
Hover each model row to inspect formulas and inputs.
+132%
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
+106%
Uses recent net income as an owner-earnings proxy and discounts scenario growth.
+165%
Solves the forward FCF growth rate implied by the current price.
Current price implies roughly 7.5% annualized FCF growth.
Estimates earnings power value without assuming growth.
+196%
Updated: 2026/04/29 15:26
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/12/31 | Asset impairment | Impairment | -444M USD | Medium |
| 2025/12/31 | Asset sale gain/loss | Asset sale gain/loss | 9M USD | Medium |
| 2024/12/31 | Asset impairment | Impairment | -419M USD | Medium |
| 2023/12/31 | Asset impairment | Impairment | -182M USD | Medium |
| 2022/12/31 | Asset sale gain/loss | Asset sale gain/loss | -214M USD | Medium |
| 2022/12/31 | Write-off | Impairment | -72M USD | Medium |
| 2021/12/31 | Other special charges | Other | -76M USD | Medium |
| 2021/12/31 | Write-off | Impairment | -8M USD | Medium |
| 2025/09/26 | Asset impairment | Impairment | -513M USD | Medium |
| 2025/06/27 | Asset impairment | Impairment | -694M USD | Medium |
| 2025/03/28 | Asset impairment | Impairment | -24M USD | Medium |
| 2024/09/27 | Asset impairment | Impairment | -526M USD | Medium |
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/12/31 | Annual | - | 4B USD | 4B USD | 5B USD | 5.05 | 5.66 |
| 2024/12/31 | Annual | - | 4B USD | 4B USD | 5B USD | 5.29 | 5.86 |
| 2023/12/31 | Annual | - | 5B USD | 5B USD | 6B USD | 6.38 | 6.62 |
| 2022/12/31 | Annual | 27B USD | 7B USD | 7B USD | 7B USD | 9.66 | 10.04 |
| 2021/12/31 | Annual | - | - | - | - | - | - |
Revenue after direct costs, useful for reading core product or service profitability.
Adjusted close trend. Current price sample covers: 2025/04/16 - 2026/04/29.